跳至主要内容
临床试验/NCT01185483
NCT01185483Unknown不适用

Endoscopic Submucosal Dissection in Upper Gastrointestinal Canal With HybridKnife

Odense University Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2009年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
20
试验地点
1

研究概览

简要总结

Endoscopic submucosal dissection (ESD) is a relatively new modality for the treatment of superficial gastrointestinal neoplasia and especially in the diagnosis and treatment of submucosal tumors. ESD has become a minimal invasive alternative to surgery but requires a high degree of endoscopic skills to be performed safely, it is time consuming, and less safe than endoscopic mucosa resection.

New endoscopic instruments have been developed to increase the efficacy and safety of ESD, and a combined endoscopic instrument (HybridKnife) has been developed and evaluated with promising results in animal studies. This HybridKnife allows high-pressure water-jet (submucosal) dissection, as well as cutting and coagulation and makes ESD possible without changing instrument.

The purpose of this study is to evaluate the feasibility and safety of using HybridKnife for ESD in humans.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Submucosal tumor (< 4 cm)
  • Mucosal tumor (T1) in patients unsuitable for surgery

排除标准

  • Endoscopic ultrasound (EUS) or CT signs of metastasis
  • Insufficient access to tumor

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验